It is with great pleasure and pride that we can announce that Kristina Martinell as of today has joined Phase2Phase.
Kristina holds a PhD (Tekn Dr) in bioprocess technology and a MSc in chemical engineering/biotechnology and is a senior professional with more than 25 years experience of bioprocess development and tech transfer, mainly within biopharma but also biotech/medical device.
Kristina's experience ranges from academia, big pharma, smaller pharma, SME startup-size companies and, lately, national and EU regulatory authorities. Her most recent position before joining Phase2Phase was as a regulator (CMC assessor for biologicals) at the Swedish MPA. Main expertise in development, characterization, and manufacture of recombinant proteins, including regulatory strategies through clinical development to commercial process, comparability, biosimilarity, control strategy development, QbD and modelling, but also general knowledge regarding vaccines, blood- and plasma-derived products and ATMPs.
We have the pleasure to announce that Mari Lif has joined our team of senior consultants.
Mari holds a Licentiate of Engineering in Biotechnology from the Royal Institute of Technology in Stockholm (KTH). She brings 30 years of experience within the field of development of bacterial and mammalian upstream processes, scale-up and manufacturing of Biopharmaceuticals, as well as quality assurance (QA) as well as QP competence. Mari brings a significant addition to our team, broadening our offer within the area of CMC and QA/QP.
We are excited to announce that Erica Rosander as of today has joined our team of senior consultants at Phase2Phase Biopharma Consulting.
Erica, holding a Master of Science in Industrial Biotechnology from the Royal Institute of Technology in Stockholm (KTH), is a Senior Professional with in-depth understanding of large scale fermentation, midstream processes, protein purification and formulation as well as peptide synthesis. Erica is also experienced in the fields of strategic manufacturing sourcing and tech transfers.
We are thrilled to announce that Annica Lübcke has joined our team of senior consultants. Annica is a senior professional with more than 20 years’ experience within the biopharmaceutical industry. Her experience ranges from project management, to leadership within Upstream GMP manufacturing, to supply chain and trade & transport compliance. Annica brings unique knowledge and experience within the field of trade compliance to our company, and will be a very competent addition to our fantastic team.
We are super excited to announce that Mats Lundgren as of today has joined our team of senior consultants at Phase2Phase. Mats, holding a PhD from the Karolinska Institute in Stockholm and post-doc training at Imperial College School of Medicine in London, is a senior professional with more than 25 years of experience in the biopharmaceutical industry. Mats will bring a significant addition to our team, broadening and strengthening our offer within the area of strategic development, cell culture production, purification and analytics of vaccines, cell and gene therapies and other ATMPs.
The new normal! After a week filled with Teams, Zoom and Skype meetings, Phase2Phase concluded the week the same way. Our first "official" virtual after work was a good start of a well deserved weekend. Cheers to you all!
We celebrated the end of the year with a Christmas get-toghether at Grand Central. Colleagues, customers and partners had a chance to mingle, discuss the main events of the year, enjoy a seminar on the hot topic of Pharmacometrics, listen to music, and just have a nice evening.
Thanks for making this Our Event of the Year!
Meet us at Nordic Life Science Days, September 10-12 at Malmömässan. During the conference Svante Almkvist and Andreas Gretander, founders and senior consultants, will be available for partnering meetings. If you are interested in our Services or Partnering opportunities, please contact us.
We are very happy and excited to announce that Josefine Bergholtz has signed on to become our second employee and senior consultant! Josefine holds a MSc in Biotechnology from the Royal Institute of Technology in Stockholm and since then she has gained a solid experience from Biologics Upstream Manufacturing, both from process development and commercial operations and quality assurance. This, and Josefine’s years of experience from the consultancy space will bring us a fantastic addition to our company.
By becoming a strategic partner with Uppsala BIO, Phase2Phase has come into contact with several interesting projects, most of them taking their first steps on their potential way into Testa Center. “Uppsala BIO has proven to be a very important asset in promoting the growth of a strong and sustainable life science sector, not only in Uppsala. With their collaboration e.g. with Umeå Biotech Incubator and also their recent expansion into the south of Sweden I hope we will see even more projects flourish in the future”, says Svante. And the future of Biopharma is yet to be created.
We are happy to announce that Joke Rotticci-Mulder yesterday signed on to become the first new employee of Phase2Phase. Joke holds a PhD from the Royal Institute of Technology where she defended her thesis “Expression and mutagenesis studies of Candida antarctica lipase B”. During the last seven years Joke has worked at Cobra Biologics and most recently as Team Manager for Purification and Analytical Development. We are fully convinced that Joke´s experience and personality will greatly contribute to the future growth of Phase2Phase.